We found 10 episodes of Oncology Today with Dr Neil Love with the tag “research to practice”.
-
Updates from the 2021 ASH Meeting on Chronic Lymphocytic Leukemia with Dr Matthew Davids
February 2nd, 2022 | Season 1 | 41 mins 4 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of chronic lymphocytic leukemia with Dr Matthew Davids, moderated by Dr Neil Love.
-
Managing Transplant-Ineligible Newly Diagnosed Multiple Myeloma with Dr Saad Zafar Usmani
January 31st, 2022 | Season 1 | 40 mins 37 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of patients with newly diagnosed multiple myeloma who are ineligible for transplant with Dr Saad Zafar Usmani, moderated by Dr Neil Love.
-
Novel Agents and Strategies for the Treatment of Metastatic Castration-Resistant Prostate Cancer with Dr Evan Yu
January 21st, 2022 | Season 1 | 41 mins 36 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of metastatic castration-resistant prostate cancer with Dr Evan Yu, moderated by Dr Neil Love.
-
Biomarker-Directed Therapy for Colorectal Cancer with Dr Christopher Lieu
January 14th, 2022 | Season 1 | 41 mins 46 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in targeted therapies for colorectal cancers with Dr Christopher Lieu, moderated by Dr Neil Love.
-
PARP Inhibition in Pancreatic Cancer with Dr Michael Pishvaian
January 12th, 2022 | Season 1 | 48 mins 10 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of pancreatic cancer with PARP with Dr Michael Pishvaian, moderated by Dr Neil Love.
-
Modern Management of Metastatic Castration-Resistant Prostate Cancer with Dr Alan Bryce
January 3rd, 2022 | Season 1 | 39 mins 1 sec
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the therapeutic landscape of metastatic castration-resistant prostate cancer with Dr Alan Bryce, moderated by Dr Neil Love.
-
Advances in Genetic Profiling and Targeted Therapies for Colorectal Cancer with Dr Arvind Dasari
December 20th, 2021 | Season 1 | 45 mins 16 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the therapeutic landscape of colorectal cancer with Dr Arvind Dasari, moderated by Dr Neil Love.
-
Ovarian Cancer with Dr Bradley Monk
December 17th, 2021 | Season 1 | 43 mins 59 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on the management of advanced ovarian cancers with Dr Bradley Monk, moderated by Dr Neil Love.
-
NSCLC with EGFR Exon 20 Insertion Mutations with Dr Gregory Riely
December 17th, 2021 | Season 1 | 35 mins 59 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on advances in the treatment of patients with NSCLC harboring an EGFR exon 20 insertion mutations with Dr Gregory Riely, moderated by Dr Neil Love.
-
Novel Immunotherapeutic Strategies in Melanoma with Dr Adil Daud
December 13th, 2021 | Season 1 | 35 mins 28 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in immunotherapeutic approaches for patients with melanoma with Dr Adil Daud, moderated by Dr Neil Love.